Liquidia LQDA
NASDAQ LQDA
$68.73 +1.05 (+1.55%)
As of: Sep 9, 2026 · 3:12 PM EDT

Liquidia (LQDA) Cash from Investing Activities (2020 - 2026)

Liquidia (LQDA) posted Cash from Investing Activities of -$12.2 million for Q2 2026, down 332.33% on a QoQ basis from -$2.8 million in Q1 2026, and down 1057.52% year-over-year from $1.3 million in Q2 2025.

Analysis

Liquidia (LQDA) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Liquidia has reported Cash from Investing Activities for 7 years, with the latest figure at -$12.2 million in Q2 2026.

  • On a quarterly basis, Cash from Investing Activities fell 1057.52% year-over-year to -$12.2 million in Q2 2026; TTM through Jun 2026 was -$20.0 million, a 152.89% decrease from a year earlier, with the FY2025 full-year figure at -$6.3 million, up 24.94% from the prior year.
  • Cash from Investing Activities was -$12.2 million for Q2 2026 at Liquidia, down from -$2.8 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was -$2000.0 in Q2 2022, with the low at -$12.2 million in Q2 2026.
  • Average Cash from Investing Activities over 5 years is -$2.5 million, with a median of -$911000.0 recorded in 2025.
  • The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities jumped 94.29% in 2022, then slumped 12050.0% in 2023.
  • Over 5 years, Cash from Investing Activities stood at -$491000.0 in 2022, then soared by 58.04% to -$206000.0 in 2023, then slumped by 2220.39% to -$4.8 million in 2024, then rose by 15.52% to -$4.0 million in 2025, then tumbled by 203.0% to -$12.2 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$12.2 million (Q2 2026), -$2.8 million (Q1 2026), and -$4.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Johnson & Johnson 646.43 Bn 625.67 Bn 17.26 Bn -1.11 Bn
2 AbbVie 442.46 Bn 435.89 Bn 12.70 Bn -1.20 Bn
3 Merck 366.77 Bn 359.63 Bn 12.21 Bn -5.60 Bn
4 Novartis Ag 266.59 Bn 258.90 Bn 11.24 Bn -3.11 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn 2.11 Bn
6 Sanofi 52.40 Bn 45.02 Bn 10.79 Bn -424.26 Mn
7 Revolution Medicines 44.08 Bn 44.08 Bn - -1.66 Bn
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn -51.79 Mn
9 United Therapeutics 21.53 Bn 18.87 Bn 683.80 Mn 87.50 Mn
10 Liquidia 6.11 Bn 5.82 Bn 160.92 Mn -12.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.24 Mn
Mar 31, 2026 -2.83 Mn
Dec 31, 2025 -4.04 Mn
Sep 30, 2025 -911,000.00
Jun 30, 2025 -1.06 Mn
Mar 31, 2025 -330,000.00
Dec 31, 2024 -4.78 Mn
Sep 30, 2024 -1.75 Mn
Jun 30, 2024 -1.29 Mn
Mar 31, 2024 -624,000.00
Dec 31, 2023 -206,000.00
Sep 30, 2023 -10.48 Mn
Jun 30, 2023 -243,000.00
Mar 31, 2023 -364,000.00
Dec 31, 2022 -491,000.00
Sep 30, 2022 -94,000.00
Jun 30, 2022 -2,000.00
Dec 31, 2021 -20,000.00
Jun 30, 2021 -35,000.00
Mar 31, 2021 -52,000.00